Page last updated: 2024-10-30

mesalamine and Endotoxin Shock

mesalamine has been researched along with Endotoxin Shock in 2 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Research Excerpts

ExcerptRelevanceReference
"A 73-year-old woman developed ulcerative colitis with mesalazine intolerance a year ago."1.91[A case of ulcerative colitis with mesalazine intolerance complicated with agranulocytosis and septic shock during salazosulfapyridine administration]. ( Eizuka, K; Honta, S; Ikehata, A; Inomata, N; Masuo, T; Ono, S; Sekino, Y, 2023)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Ikehata, A1
Honta, S1
Sekino, Y1
Masuo, T1
Eizuka, K1
Inomata, N1
Ono, S1
López-Iñiguez, A1
Pérez-Gutiérrez, MT1
Lambraño-Castillo, D1
Sierra-Madero, JG1

Other Studies

2 other studies available for mesalamine and Endotoxin Shock

ArticleYear
[A case of ulcerative colitis with mesalazine intolerance complicated with agranulocytosis and septic shock during salazosulfapyridine administration].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2023, Volume: 120, Issue:9

    Topics: Aged; Agranulocytosis; Colitis, Ulcerative; Female; Humans; Mesalamine; Shock, Septic; Sulfasalazine

2023
Necrotic lesion in an immunosuppressed patient.
    Enfermedades infecciosas y microbiologia clinica (English ed.), 2018, Volume: 36, Issue:9

    Topics: Aged; Colitis, Ulcerative; Ecthyma; Fatal Outcome; Gangrene; Humans; Immunocompromised Host; Immunos

2018